Masahiko Ando - Concepedia

Author

Masahiko Ando

Also Known As

A. Masahiko, Ando Masahiko, Ando, M, Ando, M., Ando, Masahiko, Kazumasa Yamagishi, Kenji Wakai, M Ando, M Talaat, M. ANDO

674

Publications

15.1K

Citations

H-Index

313

Concepts

All Affiliations

Nagoya University Hospital Nagoya University Kyoto University Aichi Cancer Center Nagoya Medical Center

About

Masahiko Ando is an author at Nagoya University Hospital specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	95	4.2K
2	Health Sciences	18	27	1.1K
3	Engineering	16	23	564
4	Natural Sciences	4	4	65
5	Nursing	1	1	75

Masahiko Ando

287

Publications

14K

Citations

H-Index

Page 1

	Year	Citations
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer Tomoki Ebata, Satoshi Hirano, Masaru Konishi, British journal of surgery	2018	378
Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904) Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa, Journal of Clinical Oncology	2006	365
Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib Masahiko Ando, Isamu Okamoto, Nobuyuki Yamamoto, Journal of Clinical Oncology	2006	356
Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia Yuichiro Shindo, Ryota Ito, Daisuke Kobayashi, American Journal of Respiratory and Critical Care Medicine	2013	288
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G) K. Yamazaki, Michitaka Nagase, H Tamagawa, Annals of Oncology Gastrointestinal OncologyMedicinePharmacologyColorectal CancerPathology	2016	274
Incidence of and risk factors for incisional hernia after abdominal surgery Keita Itatsu, Yukihiro Yokoyama, Gen Sugawara, British journal of surgery	2014	262
Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA) Tomoya Kawaguchi, Masahiko Ando, Kazuhiro Asami, Journal of Clinical Oncology	2014	261
Ultrathin Bronchoscopy with Multimodal Devices for Peripheral Pulmonary Lesions. A Randomized Trial Masahide Oki, Hideo Saka, Masahiko Ando, American Journal of Respiratory and Critical Care Medicine	2015	231
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR Masaru Watanabe, Tomoya Kawaguchi, Shun‐ichi Isa, Clinical Cancer Research	2015	222
Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study Tomoko Kobayashi, Shintaro Iwama, Yoshinori Yasuda, Journal of the Endocrine Society	2018	210

Page 1